 | • レポートコード：MRC2311A0183 • 出版社/出版日：360iResearch / 2023年10月25日 • レポート形態：英文、PDF、188ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医薬品 |
| Single User（1名利用、印刷不可、1年間閲覧） | ￥592,350 (USD3,949) | ▷ お問い合わせ |
| Site License（同一拠点内共有可、印刷可） | ￥1,042,350 (USD6,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 駆虫薬市場規模は、2022年の30.6億米ドルから2030年には56.8億米ドルに達し、予測期間中の年平均成長率は8.00%になると予測されます。 市場細分化とカバー範囲： この調査レポートは、駆虫薬市場の包括的な見通しを提供するために、様々なサブ市場を分析し、収益を予測し、各カテゴリの新たな動向を調査しています。 ● 薬剤クラスに基づき、市場はベンズイミダゾール系とピペラジン系で調査しています。ベンゾイミダゾール系は予測期間中に大きな市場シェアを獲得する見込みです。 ● 投与経路別では、注射剤と経口剤の市場を調査しています。予測期間中、経口剤が大きなシェアを占めると予測されます。 ● 標的病原体別では、Ancylostoma Duodenale、Ascaris Lumbricoides、Enterobius Vermicularis、Trichuris Trichiuraについて調査しています。Enterobius Vermicularisは予測期間中に大きな市場シェアを占めると予測されています。 ● 用途別では、動物用とヒト用があります。ヒトについては、消化管感染症および脳実質性神経嚢虫症についてさらに調査しています。動物は予測期間中に大きな市場シェアを獲得すると予測されています。 ● 流通チャネル別では、病院薬局、オンライン薬局、小売薬局、動物病院・診療所、動物薬局を調査しています。オンライン薬局は予測期間中に大きな市場シェアを獲得すると予測されています。 ● 地域別では、南北アメリカ、アジア太平洋、ヨーロッパ、中東、アフリカで調査を行いました。詳しい内訳は、南北アメリカはアルゼンチン、ブラジル、カナダ、メキシコ、アメリカを対象に、アメリカはさらにカリフォルニア、フロリダ、イリノイ、ニューヨーク、オハイオ、ペンシルバニア、テキサスを対象に調査を行いました。アジア太平洋地域は、オーストラリア、中国、インド、インドネシア、日本、マレーシア、フィリピン、シンガポール、韓国、台湾、タイ、ベトナムでした。ヨーロッパ・中東・アフリカは、デンマーク、エジプト、フィンランド、フランス、ドイツ、イスラエル、イタリア、オランダ、ナイジェリア、ノルウェー、ポーランド、カタール、ロシア、サウジアラビア、南アフリカ、スペイン、スウェーデン、スイス、トルコ、アラブ首長国連邦、イギリスを対象としています。2022年の市場シェアは南北アメリカが38.75%で最大、次いでヨーロッパ、中東・アフリカでした。 市場統計： 本レポートでは、主要7通貨（米ドル、ユーロ、日本円、英ポンド、豪ドル、カナダドル、スイスフラン）の市場規模と予測を提供しています。本レポートでは、2018年から2021年を過去年、2022年を基準年、2023年を推定年、2024年から2030年を予測期間としています。 FPNVポジショニングマトリックス： FPNVポジショニングマトリックスは、駆虫薬市場を評価するための不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります： フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。 市場シェア分析： 市場シェア分析では、駆虫薬市場のベンダーランドスケープに関する貴重な洞察を提供します。全体的な収益、顧客基盤、その他の主要指標に対する影響を評価することで、各社の業績と直面している競争環境について包括的な理解を提供します。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競争レベルも明らかにします。 主要企業のプロフィール： 本レポートでは、駆虫薬市場における最近の重要な動向を掘り下げ、主要ベンダーとその革新的なプロフィールを紹介しています。これには、Aden Healthcare, Anikem Laboratories, Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cipla Limited, Dechra Pharmaceuticals PLC, Dr.Reddys Laboratories Inc., Edenbridge Pharmaceuticals LLC, GlaxoSmithKline PLC, Green Cross Remedies, Healthy Life Pharma Private Limited, Johnson & Johnson Services, Inc., Kosher Pharmaceuticals, Lineage Therapeutics Inc, Lupin Limited, Mankind Pharma Ltd., McKesson Corporation, Merck & Co., Inc., Norbrook Laboratories Limited, Novartis AG, Sankur Pharmaceuticals Pvt. Ltd, Takeda Pharmaceutical Company Limited, and Virbac S.Aなどが含まれます。 本レポートでは、以下の点について貴重な洞察を提供しています： 1. 市場浸透： 主要企業の市場ダイナミクスと製品に関する包括的な情報を提供します。 2. 市場開拓： 新興市場と成熟市場セグメントへの浸透を詳細に分析し、有利な機会を強調します。 3. 市場の多様化： 新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報を記載しています。 4. 競合他社の評価とインテリジェンス： 主要企業の市場シェア、戦略、製品、認証、規制当局の承認、特許状況、製造能力を網羅的に評価しています。 5. 製品開発とイノベーション： 将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を行いました。 本レポートは、以下のような主要な質問に対応しています： 1. 駆虫薬市場の市場規模および予測はどのようになっていますか？ 2. 駆虫薬市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野はどこですか？ 3. 駆虫薬市場の機会を特定するための競争戦略窓口はどのようになっていますか？ 4. 駆虫薬市場における最新の技術動向と規制の枠組みはどのようになっていますか？ 5. 駆虫薬市場における主要ベンダーの市場シェアはどのようになっていますか？ 6. 駆虫薬市場への参入に適したモードと戦略的動きはどのようになっていますか？ |
1. 序論
2. 調査方法
3. エグゼクティブサマリー
4. 市場概要
5. 市場インサイト
6. 駆虫薬の市場分析：薬剤クラス別
7. 駆虫薬の市場分析：投与経路別
8. 駆虫薬の市場分析：対象病原体別
9. 駆虫薬の市場分析：用途別
10. 駆虫薬の市場分析：流通チャネル別
11. 南北アメリカの駆虫薬市場
12. アジア太平洋の駆虫薬市場
13. ヨーロッパ・中東・アフリカの駆虫薬市場
14. 競争状況
15. 競争ポートフォリオ
16. 付録
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Anthelmintic Drugs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing pet adoption coupled with rising focus towards maintaining animal
health
5.1.1.2. Increasing spending for animal healthcare and wellness
5.1.1.3. Accelerating prevalence of helminthic infections
5.1.2. Restraints
5.1.2.1. High cost of antiparasitic drugs
5.1.3. Opportunities
5.1.3.1. Increasing veterinary healthcare services centers
5.1.3.2. Emergence of anthelmintic drugs as immune modulators in cancer
5.1.4. Challenges
5.1.4.1. Concerns about the development of drug resistance
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Anthelmintic Drugs Market, by Drug Class
6.1. Introduction
6.2. Benzimidazoles
6.3. Piperazine
7. Anthelmintic Drugs Market, by Route of Administration
7.1. Introduction
7.2. Injectable
7.3. Oral
8. Anthelmintic Drugs Market, by Target Pathogen
8.1. Introduction
8.2. Ancylostoma Duodenale
8.3. Ascaris Lumbricoides
8.4. Enterobius Vermicularis
8.5. Trichuris Trichiura
9. Anthelmintic Drugs Market, by Application
9.1. Introduction
9.2. Animal
9.3. Human
9.4.1. Gastrointestinal Infections
9.4.2. Parenchymal Neurocysticercosis
10. Anthelmintic Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
10.5. Veterinary Hospitals & Clinics
10.6. Veterinary Pharmacies
11. Americas Anthelmintic Drugs Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Anthelmintic Drugs Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Anthelmintic Drugs Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Aden Healthcare
15.1.2. Anikem Laboratories
15.1.3. Bayer AG
15.1.4. Boehringer Ingelheim International GmbH
15.1.5. Ceva Sante Animale
15.1.6. Cipla Limited
15.1.7. Dechra Pharmaceuticals PLC
15.1.8. Dr.Reddys Laboratories Inc.
15.1.9. Edenbridge Pharmaceuticals LLC
15.1.10. GlaxoSmithKline PLC
15.1.11. Green Cross Remedies
15.1.12. Healthy Life Pharma Private Limited
15.1.13. Johnson & Johnson Services, Inc.
15.1.14. Kosher Pharmaceuticals
15.1.15. Lineage Therapeutics Inc
15.1.16. Lupin Limited
15.1.17. Mankind Pharma Ltd.
15.1.18. McKesson Corporation
15.1.19. Merck & Co., Inc.
15.1.20. Norbrook Laboratories Limited
15.1.21. Novartis AG
15.1.22. Sankur Pharmaceuticals Pvt. Ltd
15.1.23. Takeda Pharmaceutical Company Limited
15.1.24. Virbac S.A.
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. ANTHELMINTIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 6. ANTHELMINTIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ANTHELMINTIC DRUGS MARKET SIZE, BY PIPERAZINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 9. ANTHELMINTIC DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ANTHELMINTIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 12. ANTHELMINTIC DRUGS MARKET SIZE, BY ANCYLOSTOMA DUODENALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ANTHELMINTIC DRUGS MARKET SIZE, BY ASCARIS LUMBRICOIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ANTHELMINTIC DRUGS MARKET SIZE, BY ENTEROBIUS VERMICULARIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ANTHELMINTIC DRUGS MARKET SIZE, BY TRICHURIS TRICHIURA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 20. ANTHELMINTIC DRUGS MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. ANTHELMINTIC DRUGS MARKET SIZE, BY PARENCHYMAL NEUROCYSTICERCOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. ANTHELMINTIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. ANTHELMINTIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. ANTHELMINTIC DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. ANTHELMINTIC DRUGS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. ANTHELMINTIC DRUGS MARKET SIZE, BY VETERINARY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 40. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 46. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 48. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 50. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 52. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 54. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 56. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 73. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 78. AUSTRALIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 80. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 81. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 82. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 84. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 86. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 88. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 90. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 92. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 94. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 98. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 100. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 102. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 104. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 110. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. SINGAPORE ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 126. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. TAIWAN ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 132. TAIWAN ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 134. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 136. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 138. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. VIETNAM ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 142. VIETNAM ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. VIETNAM ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 144. VIETNAM ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. DENMARK ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 153. DENMARK ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. DENMARK ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 155. DENMARK ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. DENMARK ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 157. DENMARK ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. EGYPT ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 159. EGYPT ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. EGYPT ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 161. EGYPT ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. EGYPT ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 163. EGYPT ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. FINLAND ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 165. FINLAND ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. FINLAND ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 167. FINLAND ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. FINLAND ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 169. FINLAND ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 171. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 172. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 173. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 175. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 177. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 179. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 181. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 187. ISRAEL ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 188. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 189. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 190. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 191. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 193. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. NIGERIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 201. NIGERIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 202. NIGERIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 203. NIGERIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. NIGERIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 205. NIGERIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. NORWAY ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 207. NORWAY ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. NORWAY ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 209. NORWAY ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. NORWAY ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 211. NORWAY ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. POLAND ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 213. POLAND ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. POLAND ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 215. POLAND ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. POLAND ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 217. POLAND ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 219. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 220. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 221. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 223. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 243. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 244. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 245. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 247. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. TURKEY ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 261. TURKEY ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 262. TURKEY ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 263. TURKEY ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. TURKEY ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 265. TURKEY ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 274. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. ANTHELMINTIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 279. ANTHELMINTIC DRUGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 280. ANTHELMINTIC DRUGS MARKET LICENSE & PRICING